Surgery Websites
Melanoma Surgery »  Faculty »  Surgery »  Michael D. Alvarado, M.D.
Michael D. Alvarado, M.D.

Michael D. Alvarado, M.D.

Associate Professor of Surgery
Division of General Surgery
Director, Breast Surgery Oncology Fellowship

Contact Information

Academic Office
415-353-7908
415-353 9571 - Fax
michael.alvarado@ucsf.edu

Open Popup
  • 1985-89, Arizona State University, BS, Chemistry
  • 1990-92, University of Arizona, Physical Chemistry, MA
  • 1994-98, Dartmouth Medical School, MD
  • 1998-04, Surgical Residency, Dartmouth Hitchcock Medical Center
  • 1998-03, Surgical Residency, Dartmouth Medical School
  • 2003-04, Chief Resident, Surgery, Dartmouth Medical School
  • 2004-06, Surgical Oncology, H. Lee Moffitt Cancer Center
  • 2005, American Board of Surgery
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Melanoma Center
  • Carol Franc Buck Breast Care Center
  • Investigation of blood-based and molecular markers to improve breast cancer screening
  • Sentinel Lymph Node Biopsy

Michael Alvarado, M.D. is an Assistant Professor of Surgery and member of the breast care and melanoma programs. Dr. Alvarado received his undergraduate degree from Arizona State University, his master's degree in chemistry from the University of Arizona and his medical degree from Dartmouth Medical School.

After completing his residency at Dartmouth-Hitchcock Medical Center, he completed his surgical oncology fellowship at the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida. There he conducted research in the Department of Interdisciplinary Oncology on comparative gene expression profiling of stage III colon cancer and sentinel lymph node biopsy for patients undergoing mastectomy.

Dr. Alvarado plays an integral role in the world-renowned multidisciplinary breast care team at the Carol Franc Buck Breast Care Center in  the UCSF Helen Diller Family Comprehensive Cancer Center. He is also Director of the Breast Surgical Oncology Fellowship Program and is intimately involved in the training of breast cancer surgeons of the future. 

Dr. Alvarado performs melanoma surgery including sentinel lymph node biopsy at the UCSF Melanoma Center, a multidisciplinary program consisting of melanoma surgeons, dermatologists, medical oncologists, dermatopathologist and head and neck surgeon.

Highly respected by his peers, Dr. Alvarado was named to the list of U.S. News "Top Doctors," which denotes the top 10% of physicians within a region practicing a given specialty. Dr. Alvarado is certified by the American Board of Surgery, member of the Society of Surgical Oncology and member of the American College of Surgeons.  

  

 

 

 

 

Publications provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 66
Publications provided by UCSF Profiles, powered by CTSI
  1. Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Jun 08. View in PubMed
  2. Levine LS, Mahuron KM, Tsai KK, Wu C, Mattis DM, Pauli ML, Oglesby A, Lee JC, Spitzer MH, Krummel MF, Algazi AP, Rosenblum MD, Alvarado M, Daud AI. Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma. Ann Surg Oncol. 2020 Jun 02. View in PubMed
  3. Vaidya JS, Bulsara M, Saunders C, Flyger H, Tobias JS, Corica T, Massarut S, Wenz F, Pigorsch S, Alvarado M, Douek M, Eiermann W, Brew-Graves C, Williams N, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Baum M, Joseph D. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer. JAMA Oncol. 2020 Apr 02; e200249. View in PubMed
  4. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. View in PubMed
  5. Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. NPJ Breast Cancer. 2019; 5:29. View in PubMed
  6. View All Publications

 

Site Directory
    X